KSC · 004310.KS
Hyundai Pharmaceutical Co., Ltd.
₩6,570-₩110 (-1.65%)
Hyundai Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 58.83% below the high.
Loading market information…
KSC · 002620.KS · KRW
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
Jeil Pharma Holdings Inc’s quoted price sits in the lower half of its reported 52-week range, 31.78% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Jeil Pharma Holdings Inc’s forward annual dividend is ₩70 per share, paid annual. The forward yield is 1.04% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Jeil Pharma Holdings Inc’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Jeil Pharma Holdings Inc. is a South Korean pharmaceutical enterprise focused on the production and sale of active pharmaceutical ingredients (APIs), incrementally modified drugs (IMDs), and generic pharmaceuticals. The company's comprehensive API portfolio encompasses a variety of therapeutic areas, including antimicrobials, gastrointestinal remedies, cardiovascular medications, neuropsychiatric treatments, oncology drugs, endocrinology products, urology solutions, antivirals, and antihistamines, in addition to transdermal patch formulations. Furthermore, Jeil Pharma Holdings offers a broad selection of finished dosage forms addressing conditions such as bacterial, fungal, and viral infections; cardiovascular and endocrine disorders; neurological and gastrointestinal ailments; urological and oncological diseases. Its extensive range also features antihistamines, rheumatology, respiratory, otolaryngological, hepatic, and purgative agents. With a global presence, Jeil Pharma Holdings Inc. exports its products to approximately 40 countries, spanning regions like Southeast Asia, Central and South America, and Africa. Founded in 1959, the company's headquarters are situated in Seoul, South Korea.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:49 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₩6,570-₩110 (-1.65%)
Hyundai Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 58.83% below the high.
₩10,400-₩80 (-0.76%)
Whan In Pharm Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 14.33% below the high.
₩21,150-₩650 (-2.98%)
Ilsung Is Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.82% below the high.
₩8,600-₩230 (-2.6%)
Jeil Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 55.42% below the high.
₩5,140-₩10 (-0.19%)
Kyongbo Pharmaceutical Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 44.73% below the high.
₩1,203-₩27 (-2.2%)
SAMSUNG PHARM. Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.15% below the high.
₩8,210-₩170 (-2.03%)
HANDOK Inc.’s quoted price sits in the lower half of its reported 52-week range, 32.43% below the high.
₩12,330-₩20 (-0.16%)
CKD Bio Corp.’s quoted price sits in the lower half of its reported 52-week range, 50.48% below the high.
